Mutations in the Txnip PPXY motifs protect against myocardial infarction despite enhanced protein stability

Yoshinobu Nakayama1, Atsuhiro Kitaura1, Syed Amir Abdali1

  • 1Department of Molecular, Cellular & Biomedical Sciences, City University of New York School of Medicine, New York, New York, United States.

Insights

Mutating the PPXY motifs in thioredoxin-interacting protein (Txnip) stabilizes the protein but protects the heart from injury. This suggests Txnip levels do not always correlate with cardiotoxicity, offering new therapeutic avenues for heart disease.

Area of Science:

  • Cardiovascular Biology
  • Molecular Mechanisms of Disease
  • Protein Regulation

Background:

  • Thioredoxin-interacting protein (Txnip) exacerbates heart disease by increasing oxidative and metabolic stress.
  • Txnip possesses C-terminal PPXY motifs crucial for α-arrestin function, but their role in Txnip's cardiotoxicity is unclear.

Purpose of the Study:

  • To investigate the physiological role of Txnip's PPXY motifs in regulating its function and cardiotoxicity.
  • To determine if disrupting these motifs can offer cardioprotection.

Main Methods:

  • Utilized site-directed mutagenesis to alter Txnip PPXY motifs to AAXA in cell culture and engineered inducible, cardiomyocyte-restricted knock-in mice.
  • Assessed cellular stress, cell death, cardiac function post-myocardial infarction, protein ubiquitination, and transcriptional changes.
  • Employed structural modeling to identify binding partners and transcriptomic profiling.

Main Results:

  • Mutant Txnip (PPXY-to-AAXA) retained canonical functions but attenuated cell death.
  • Inducible knock-in mice with mutated Txnip were protected against myocardial infarction, showing improved cardiac function and survival.
  • The PPXY mutation abolished Txnip ubiquitination by the E3 ligase ITCH, stabilizing Txnip protein and downregulating AP-1 network genes post-injury.

Conclusions:

  • Txnip PPXY motifs are critical for regulating Txnip protein turnover and injury-induced transcriptional responses.
  • Disrupting these motifs paradoxically stabilizes Txnip protein while conferring significant cardioprotection.
  • Elevated Txnip levels do not invariably drive cardiotoxicity, challenging existing paradigms in heart disease pathogenesis.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
80
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
155
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
113
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
9.3K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
631